Long COVID & Psychedelics: Can Psilocybin and MDMA Support Recovery?
An examination of emerging evidence for psychedelic-assisted therapy in Long COVID — including the published case report of MDMA and psilocybin reversing persistent Long-COVID symptoms, proposed mechanisms involving neuroinflammation and serotonin signaling, and the research agenda this opens.
Content Coming Soon
This resource is being prepared and will be available shortly.
Source Research Papers
Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar.
Chopra, H., Furnish, T., Verduzco-Gutierrez, M., Jevotovsky, D. S., & Castellanos, J. (2024). Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report. Clinical Case Reports, 12, e8791. https://doi.org/10.1002/ccr3.8791
Shop Related Spores
Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.